Drugs / [18F]MK-0947
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07348250 | Dec 2025 → Oct 2026 expected | Parkinson disease | Invicro | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]MK-0947 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07348250 ↗ |
| Modality | Diagnostic / imaging agent | “new imaging drug” NCT07348250 ↗ |
| Route | Intravenous | “administered IV” NCT07348250 ↗ |